Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do you know your total cholesterol (TC) number?

Cong Chen1, Zhigang Zhou, Robert W Tipping

  • 1Merck Research Laboratories, West Point, PA 19486, USA. cong_chen@merck.com

Journal of Biopharmaceutical Statistics
|November 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study on the Inhibitory Effects of Naringenin-Loaded Nanostructured Lipid Carriers Against Nonalcoholic Fatty Liver Disease.

Journal of biomedical nanotechnology·2021
Same author

Designing Zn-doped nickel sulfide catalysts with an optimized electronic structure for enhanced hydrogen evolution reaction.

Nanoscale·2021
Same author

Clinical characteristics of low-grade tumor-related epilepsy and its predictors for surgical outcome.

Annals of clinical and translational neurology·2021
Same author

Switching Spinless and Spinful Topological Phases with Projective PT Symmetry.

Physical review letters·2021
Same author

Comparison of Duration of Response vs Conventional Response Rates and Progression-Free Survival as Efficacy End Points in Simulated Immuno-oncology Clinical Trials.

JAMA network open·2021
Same author

Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT.

Frontiers in pharmacology·2021
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Estimating true cholesterol levels is vital for healthcare policy. A new mixture-of-normals model improves accuracy over traditional methods, offering better insights into individual cholesterol distributions.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Health Policy

Background:

  • Total cholesterol (TC) measurements are prone to errors due to natural within-individual variations over time.
  • Accurate estimation of true TC distribution is crucial for healthcare policy and management.
  • Existing methods often assume normality, which may not reflect true cholesterol distributions.

Purpose of the Study:

  • To develop a more accurate method for estimating the distribution of true total cholesterol (TC).
  • To address the limitations of current estimators that rely on normality assumptions.

Main Methods:

  • Proposed a constrained maximum likelihood estimator (MLE).
  • Utilized a mixture-of-normals model to approximate the true TC distribution.
  • Conducted a simulation study to compare the proposed estimator with a normality-based estimator.

Related Experiment Videos

Main Results:

  • The proposed mixture-of-normals estimator demonstrated superior performance compared to the normality assumption estimator in simulations.
  • The new method accurately estimated the distribution function of true TC.
  • Application to real-world data confirmed the enhanced performance over the traditional approach.

Conclusions:

  • The constrained maximum likelihood estimator based on a mixture-of-normals model provides a more accurate approach to estimating true total cholesterol distributions.
  • This method offers significant improvements for healthcare policy and management by providing a better understanding of individual cholesterol variability.
  • The findings challenge the widespread use of normality assumptions in analyzing cholesterol data.